An improved mouse orthotopic bladder cancer model exhibiting progression and treatment response characteristics of human recurrent bladder cancer.

Naito, Tomoharu; Higuchi, Tamami; Shimada, Yasuhiro; Kakinuma, Chihaya

Naito, Tomoharu; Higuchi, Tamami; Shimada, Yasuhiro; Kakinuma, Chihaya.

Afiliação

Naito T; Pharmaceutical and Healthcare Research Laboratories, FUJIFILM Corporation, Ashigarakami-gun, Kanagawa 258-8577, Japan.
Higuchi T; Department of Human Pathology, School of Medicine, Juntendo University, Tokyo 113-0033, Japan.
Shimada Y; Pharmaceutical and Healthcare Research Laboratories, FUJIFILM Corporation, Ashigarakami-gun, Kanagawa 258-8577, Japan.
Kakinuma C; Department of Oncology Clinical Development, Gunma University, Graduate School of Medicine, Maebashi, Gunma 371-8511, Japan.

Oncol Lett ; 19(1): 833-839, 2020 Jan.

Article em En | MEDLINE | ID: mdl-31885717

Palavras-chave

bladder cancer; chemotherapy; cisplatin; gemcitabine; microtumor; orthotopic mouse model; pathology; superficial bladder cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Oncol Lett Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google